Get Adobe Flash player


Authors: Volosovets T.N.

Pages: 199-208


Introduction. Lesions of periodontal herpesvirus is a complex process and is carried out by direct viral infection and replication, or due to virus-induced changes in the immune system. The prevalence of dystrophic and inflammatory lesions parodonta in the population; the complexity in the implementation of prevention and treatment of disease, and the ambiguity in the interpretation of the basic pathogenetic mechanisms (interrelated inflammatory, immune and metabolic) makes this issue extremely important in medicine.

Our aim was to detect viral DNA viruses of the family Herpesviridae in oral fluid of patients with inflammatory and dystrophic-inflammatory periodontal disease, associated with persistent herpes virus infection.

Material and methods. PCR and ELISA was performed detection and identification of viral DNA viruses of the family Herpesviridae in oral fluid of patients with inflammatory and dystrophic-inflammatory periodontal disease, associated with persistent herpes virus infection. I examined 290 patients with inflammatory and dystrophic-inflammatory periodontal disease (catarrhal gingivitis, generalized periodontitis (CP) and the initial and degree) and, depending on the presence or absence of persistent HVI divided them into groups.

Within the study was conducted immunological study of 170 patients with pathology of periodontal tissues infected by viruses of the family Herpesviridae (Experimental (I) group).

Results. As a result of the survey it was found that 170 (52.79 %) patients had relatively persistent HVI of virus and made D (I) group. 42.21% of patients had persistent HVI available and made the comparison group (II).


    1. During the polymerase chain reaction (PCR) in oral fluid of 170 patients of the main group reproduction HVI was detected only in 38.82 % of subjects: the herpes simplex virus (HSV) 1 and 2 – in 26.46 % of patients;–; the cytomegalovirus (CMV ) – in 10.58 % of patients. With greatest frequency in oral fluid was observed reproduction HSV 1 and type 2.
    2. Evaluating the local immunity by ELISA, IgM class antibodies to HSV RR was found in ; on EBV – in 3.77% of patients; to CMV – in 3.53 % of individuals.
    3. IgG class antibodies to EBV were determined in 51.76 % of patients; to CMV – in 68.23 % of patients; to HSV 1 and 2 – in 88.23 % of patients.

Key words: salpingoophoritis, inflammation, adolescents, IL-1β gene 511C/T.

        This email address is being protected from spambots. You need JavaScript enabled to view it.    

The full text

To view the full text



  1. Volf GF, Rateitskhak YeM, Rateitskhal K. Parodontologiia [Parodontology]. Moscow: MEDpress Inform Publ., 2008. 548 p.
  2. Polovtseva TV, Karazhas NV, Kalugina MYu, Mamedova EA, Finogenova NA, Lavrenteva IN. [How to diagnose herpes virus infection in children of early age]. Detskieinfektsii. 2012;2:51–53.
  3. Zorina OA, Berkutova IS, Rekhviashvili BA, Antitdze MK. [The comparative characteristic of the parodontal recesses in patients with chronic generalized and severe periodontitis before and after the complex treatment]. Rossiiskii stomatologicheskii zhurnal. 2013;1:27–31.
  4. Kravchenko LV, Afonin AA, Demidova MV. [Disturbance in the immune system in herpes virus infection]. Detskiebolezni.2012;1:33–37.
  5. Kuzmina YeM, Vasina SA, Kuzmina IN, Vasina SA, Petrina SE.[Modern criteria to evaluate dental status during the epidemiological survey of the population]Rossiiskii stomatologicheskii zhurnal. 2009;4:27.
  6. Lvov ND, Bavykin AS, Mel'nichenko AV, Karpukhin AV. [The blocking effects of small interfering RNAs on RS-1 gene functions of herpes simplex virus type 2: new perspectives for targeted antiviral exposure]. Voprosy Virusologii. 2012;57(3):14–6.
  7. Lamont RJ, Lantz MS, Burne RA, Leblanc DJ, editors. Oral microbiology and immunology. ASM Press, 2006. 475 p.
  8. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein–Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835–49. doi: 10.1182/blood-2010-11-316745.
  9. Contreras A, Slots J. Herpesviruses in human periodontal disease. Journal of Periodontal Research. 2000;35(1):3–16.
  10. Jonsson B, Ohrn K, Lindberg P, Oscarson N. Cost-effectiveness of an individually tailored oral health educational programme based on cognitive behavioural strategies in non-surgical periodontal treatment. Journal of Clinical Periodontology. 2012;39(7):659–65. doi: 10.1111/j.1600-051X.2012.01898.x
  11. Kawaguchi Y. Herpes simplex virus (HSV). Virusy. 2010;60(2):187–196.
  12. Li X, Lan HY, Huang XR, Zhang C, Jin LJ. Expression profile of macrophage migration-inhibitory factor in human gingiva and reconstituted human gingival epithelia stimulated by Porphyromonas gingivalis lipopolysaccharide. Journal of Periodontal Research. 2013;48(4):527–32. doi: 10.1111/jre.12035
  13. Lin YL, Li M. Human cytomegalovirus and Epstein-Barr virus inhibit oral bacteria-induced macrophage activation and phagocytosis. Oral Microbiology and Immunology. 2009;24(3):243–8. doi: 10.1111/j.1399-302X.2009.00504.x
  14. Ohrn K, Jonsson B. A comparison of two questionnaires measuring oral health-related quality of life before and after dental hygiene treatment in patients with periodontal disease. International Journal of Dental Hygiene. 2012;10(1):9–14. doi: 10.1111/j.1601-5037.2011.00511.x
  15. Passariello C, Palamara A, Garaci E, Pasquantonio G. Herpesviruses and periodontal disease: a cautionary tale. International JImmunopathology and Pharmacology. 2009;22(2):263–268.